Skip to main content
Home
FULL MENU Close Menu
Home
Home

Sharon Worcester

Sharon Worcester is an award-winning medical journalist for MDedge News. She has been with the company since 1996, first as the Southeast Bureau Chief (1996-2009) when the company was known as International Medical News Group, then as a freelance writer (2010-2015) before returning as a reporter in 2015. She previously worked as a daily newspaper reporter covering health and local government. Sharon currently reports primarily on oncology and hematology. She has a BA from Eckerd College and an MA in Mass Communication/Print Journalism from the University of Florida. Connect with her via LinkedIn and follow her on twitter @SW_MedReporter.

News

Late effects in young cancer survivors underscore importance of high-risk screening

Author:
Sharon Worcester
Publish date: February 21, 2020

Childhood cancer survivors have higher standardized mortality ratios than early-adolescent and young adult cancer survivors.

  • Read More

News

Adolescent obesity linked with midlife cancer risk

Author:
Sharon Worcester
Publish date: February 21, 2020

Investigators say teen obesity could be an important intervention target for subsequent cancer prevention.

  • Read More

News

Synovial biopsy findings drive precision medicine for RA closer to the clinic

Author:
Sharon Worcester
Publish date: February 19, 2020

“I think synovial biopsies will yield a lot of information and really, hopefully, help us target therapy and find new therapeutic targets that we...

  • Read More

News

Tramadol use for noncancer pain linked with increased hip fracture risk

Author:
Sharon Worcester
Publish date: February 14, 2020

"Our results point to the need to consider tramadol's associated risk of fracture in clinical practice and treatment guidelines," the researchers...

  • Read More

News

IFN-activated monocytes show early promise for ovarian cancer

Author:
Sharon Worcester
Publish date: February 13, 2020

ORLANDO - Two of 11 patients achieved a partial response, and there were no grade 4-5 adverse events.

  • Read More

News

Model reveals genes associated with prognosis in ER+, HER2– breast cancer

Author:
Sharon Worcester
Publish date: February 12, 2020

ORLANDO – A model revealed 5 genes associated with poor prognosis and 15 genes associated with good prognosis.

  • Read More

News

Phase 2 data: Inotuzumab, approved in adults with B-ALL, shows promise in kids, too

Author:
Sharon Worcester
Publish date: February 11, 2020

“Importantly, there were no inotuzumab dose modifications or delays due to hepatic toxicity.”

  • Read More

News

Adding ilixadencel improved outcomes in metastatic renal cell carcinoma

Author:
Sharon Worcester
Publish date: February 10, 2020

ORLANDO – Ilixadencel improved responses when added to sunitinib as first-line therapy in patients with synchronous metastatic renal cell...

  • Read More

News

The 2019 novel coronavirus: Case review IDs clinical characteristics

Author:
Sharon Worcester
Publish date: February 5, 2020

A review of coronavirus pneumonia cases in Wuhan, China, suggests older men and those with comormid conditions are most likely to be affected by...

  • Read More

News

Deferiprone noninferior to deferoxamine for iron overload in SCD, rare anemias

Author:
Sharon Worcester
Publish date: February 2, 2020

An oral iron chelator granted accelerated approval for thalassemia is noninferior to deferoxamine for iron overload in patients with sickle cell...

  • Read More

News

Psoriasis: A look back over the past 50 years, and forward to next steps

Author:
Sharon Worcester
Publish date: January 29, 2020

“The progress has been breathtaking – there’s no other way to describe it.”

  • Read More

News

Registry data reveal temporal relationship between psoriasis symptoms and PsA onset

Author:
Sharon Worcester
Publish date: January 29, 2020

ATLANTA – Age at the onset of psoriasis was the main factor that determined PsA symptom synchronicity, according a study of data from the PsART...

  • Read More

News

Phase 2 study shows regimen benefit with dasatinib in Ph+ALL therapy

Author:
Sharon Worcester
Publish date: January 22, 2020

Dasatinib-based two-step induction and intensive consolidation before alloHCT for Ph+ALL extends benefits of TKI...

  • Read More

News

Sevuparin failed for acute VOC in sickle cell, but may have preventive potential

Author:
Sharon Worcester
Publish date: January 21, 2020

The novel nonanticoagulant heparinoid drug sevuparin may have value in the setting of prodromal vaso-occlusive crisis in patients with SCD.

  • Read More

News

Liver fibrosis scores predict CV event risk associated with NAFLD

Author:
Sharon Worcester
Publish date: January 16, 2020

NAFLD is associated with a twofold increase in cardiovascular events, and liver fibrosis in NAFLD is associated with a fourfold increase.

  • Read More

Pages

  • « first
  • …
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • …
  • last »

Privacy Policy

Do Not Sell My Personal Information

Terms of Use

Editorial Policy

Cookie Policy

Ad Policy

Medscape Customer Support

Frequently Asked Questions

 

Advertise with MDedge

See more with MDedge! See our Other Publications

MDedge: Keeping You Informed. Saving You Time.

Copyright  © 2021 Frontline Medical Communications Inc., Parsippany, NJ, USA. All rights reserved. Unauthorized use prohibited. The information provided is for educational purposes only. Use of this Web site is subject to the medical disclaimer.

Close